Drawing for JAXIALLE

USPTO serial 79330110

JAXIALLE

Reviewed by CopyMark Law Group

Reg. 6777010Status 404
Filing date
Status date
Registration date
Jul 5, 2022
Examiner
WU, KRISTEN ZAHNOW
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JAXIALLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION
Dec 25, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 25, 2025DETHDEATH OF INTERNATIONAL REGISTRATION
Sep 25, 2022GPNXNOTIFICATION PROCESSED BY IB
Sep 6, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2022FIMPFINAL DISPOSITION PROCESSED
Aug 4, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 5, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 5, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 9, 2022GPNXNOTIFICATION PROCESSED BY IB
Apr 19, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 19, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 13, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 30, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2022DOCKASSIGNED TO EXAMINER
Jan 26, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 26, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 26, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 26, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 26, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 14, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Jan 10, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 30, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance